These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7024639)

  • 1. An evaluation of EMIT-dau Benzodiazepine Metabolite Assay for urine drug screening.
    Poklis A
    J Anal Toxicol; 1981; 5(4):174-6. PubMed ID: 7024639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay.
    Fraser AD
    J Anal Toxicol; 1987; 11(6):263-6. PubMed ID: 3323671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of EMIT benzodiazepine assay with GLC/NPD.
    Verebey K; Jukofsky D; Mulé SJ
    J Anal Toxicol; 1982; 6(6):305-8. PubMed ID: 6761510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of the Emit-dau system in the examination of cadaveric urine].
    Szathmary S; Daldrup T
    Z Rechtsmed; 1984; 92(2):101-7. PubMed ID: 6372310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography.
    Borggaard B; Joergensen I
    J Anal Toxicol; 1994 Sep; 18(5):243-6. PubMed ID: 7990439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary screening for adinazolam and its major metabolites by the Emit d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC.
    Fraser AD; Isner AF; Bryan W
    J Anal Toxicol; 1993; 17(7):427-31. PubMed ID: 8309217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of the EMIT drug abuse urine assay methods.
    Allen LV; Stiles ML
    Clin Toxicol; 1981 Sep; 18(9):1043-65. PubMed ID: 7032834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme immunoassay method for comprehensive drug screening in micro-samples of urine.
    Black DL; Goldberger BA; Caplan YH
    Clin Chem; 1987 Mar; 33(3):367-71. PubMed ID: 3545536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive EMIT indication of opiates and methadone in a doxylamine intoxication.
    Hausmann E; Kohl B; von Boehmer H; Wellhöner HH
    J Clin Chem Clin Biochem; 1983 Oct; 21(10):599-600. PubMed ID: 6358402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of TDx cocaine metabolite assay.
    Poklis A
    J Anal Toxicol; 1987; 11(5):228-30. PubMed ID: 3682784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine benzodiazepines screening of involuntarily drugged and robbed or raped patients.
    Boussairi A; Dupeyron JP; Hernandez B; Delaitre D; Beugnet L; Espinoza P; Diamant-Berger O
    J Toxicol Clin Toxicol; 1996; 34(6):721-4. PubMed ID: 8941203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of benzo- and thienodiazepines in urine with Emit ST and thin-layer chromatography within the scope of substance abuse].
    Gruhl H
    Z Rechtsmed; 1987; 98(4):221-8. PubMed ID: 2889301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.
    Cone EJ; Yousefnejad D; Dickerson SL
    J Forensic Sci; 1990 Jul; 35(4):786-91. PubMed ID: 2202774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
    Jones CE; Wians FH; Martinez LA; Merritt GJ
    Clin Chem; 1989 Jul; 35(7):1394-8. PubMed ID: 2667799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug screening by enzyme immunoassay (EMIT) and thin-layer chromatography (Drug Skreen).
    Oellerich M; Külpmann WR; Haeckel R
    J Clin Chem Clin Biochem; 1977 May; 15(5):275-83. PubMed ID: 330794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of enzyme immunoassay and gas chromatography/mass spectrometry in forensic toxicology.
    Fenton J; Schaffer M; Chen NW; Bermes EW
    J Forensic Sci; 1980 Apr; 25(2):314-9. PubMed ID: 6993619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.